As of Mar 27
| +4.02 / +3.74%|
The 3 analysts offering 12-month price forecasts for USANA Health Sciences Inc have a median target of 101.00, with a high estimate of 125.00 and a low estimate of 100.00. The median estimate represents a -9.32% decrease from the last price of 111.38.
The current consensus among 3 polled investment analysts is to Hold stock in USANA Health Sciences Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.